Polymorphismmodel | Population | No. of studies | Test of association | Test of heterogeneity | ||||
---|---|---|---|---|---|---|---|---|
(Cases/Controls) | OR | 95%CI | PZ value | Model | PQ value | I2 | ||
rs2066853 G>A | ||||||||
AA+GA vs. GGa | Overall | 17 (9496/9977) | 1.008 | 0.898–1.131 | 0.899 | R | < 0.0001 | 66.662 |
Asians | 9 (3851/3983) | 1.093 | 0.885–1.351 | 0.408 | R | < 0.0001 | 78.872 | |
Chinese | 5 (2065/2289) | 1.168 | 0.846–1.614 | 0.345 | R | < 0.0001 | 81.794 | |
Caucasians | 3 (2102/2423) | 1.001 | 0.869–1.154 | 0.985 | F | 0.383 | 0 | |
lung cancer | 6 (2046/2245) | 0.904 | 0.721–1.134 | 0.384 | R | 0.021 | 62.421 | |
breast cancer | 4 (3031/3057) | 1.014 | 0.791–1.300 | 0.912 | R | 0.004 | 77.604 | |
AA vs. GA+GGb | Overall | 17 (9496/9977) | 0.994 | 0.860–1.149 | 0.937 | R | 0.099 | 32.183 |
Asians | 9 (3851/3983) | 0.955 | 0.834–1.093 | 0.503 | F | 0.133 | 35.627 | |
Chinese | 5 (2065/2289) | 1.018 | 0.848–1.222 | 0.849 | F | 0.143 | 41.746 | |
Caucasians | 3 (2102/2423) | 1.536 | 0.991–2.382 | 0.055 | F | 0.485 | 0 | |
lung cancer | 6 (2046/2245) | 0.899 | 0.736–1.098 | 0.298 | F | 0.158 | 37.238 | |
breast cancer | 4 (3031/3057) | 0.944 | 0.804–1.109 | 0.482 | F | 0.459 | 0 | |
AA vs. GGc | Overall | 17 (9496/9977) | 1.038 | 0.868–1.242 | 0.679 | R | 0.011 | 49.276 |
Asians | 9 (3851/3983) | 1.024 | 0.797–1.315 | 0.856 | R | 0.007 | 62.256 | |
Chinese | 5 (2065/2289) | 1.157 | 0.791–1.694 | 0.452 | R | 0.014 | 67.815 | |
Caucasians | 3 (2102/2423) | 1.522 | 0.981–2.361 | 0.061 | F | 0.479 | 0 | |
lung cancer | 6 (2046/2245) | 0.903 | 0.728–1.120 | 0.351 | F | 0.102 | 45.628 | |
breast cancer | 4 (3031/3057) | 0.948 | 0.801–1.122 | 0.534 | F | 0.122 | 48.2 | |
A vs. Gd | Overall | 17 (9496/9977) | 0.995 | 0.911–1.086 | 0.906 | R | < 0.0001 | 63.137 |
Asians | 9 (3851/3983) | 1.031 | 0.888–1.198 | 0.686 | R | < 0.0001 | 76.933 | |
Chinese | 5 (2065/2289) | 1.105 | 0.883–1.383 | 0.381 | R | 0.001 | 79.311 | |
Caucasians | 3 (2102/2423) | 1.039 | 0.914–1.181 | 0.557 | F | 0.396 | 0 | |
lung cancer | 6 (2046/2245) | 0.904 | 0.769–1.063 | 0.221 | R | 0.043 | 56.320 | |
breast cancer | 4 (3031/3057) | 0.993 | 0.831–1.185 | 0.936 | R | 0.009 | 73.976 | |
rs7796976 G>A | ||||||||
AA+GA vs. GGa | Overall | 3 (2489/2415) | 0.928 | 0.829–1.040 | 0.198 | F | 0.458 | 0.000 |
AA vs. GA+GGb | Overall | 3 (2489/2415) | 0.932 | 0.759–1.145 | 0.504 | F | 0.738 | 0.000 |
AA vs. GGc | Overall | 3 (2489/2415) | 0.897 | 0.725–1.110 | 0.319 | F | 0.557 | 0.000 |
A vs. Gd | Overall | 3 (2489/2415) | 0.942 | 0.862–1.030 | 0.191 | F | 0.447 | 0.000 |
rs2074113 C>A | ||||||||
AA+CA vs. CCa | Overall | 3 | 1.021 | 0.895–1.165 | 0.755 | F | 0.613 | 0.000 |
AA vs. CA+CCb | Overall | 3 | 0.895 | 0.706–1.135 | 0.361 | F | 0.275 | 22.596 |
AA vs. CCc | Overall | 3 | 0.950 | 0.739–1.220 | 0.686 | F | 0.377 | 0.000 |
A vs. Cd | Overall | 3 | 0.992 | 0.893–1.102 | 0.876 | F | 0.574 | 0.000 |